[
  {
    "ts": "2026-02-03T01:50:55+00:00",
    "headline": "Google, Amazon, Nvidia Lead Earnings Barrage. Here's How To Get Ready.",
    "summary": "Welcome to a revamped How To Invest newsletter as upcoming earnings from Google, Amazon and more bring these rules into focus.",
    "url": "https://www.investors.com/how-to-invest/how-to-invest-google-amazon-nvidia-lead-earnings-barrage-how-to-get-ready/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "aca8ec15-7d9b-337b-936d-7c0ff1638750",
      "content": {
        "id": "aca8ec15-7d9b-337b-936d-7c0ff1638750",
        "contentType": "STORY",
        "title": "Google, Amazon, Nvidia Lead Earnings Barrage. Here's How To Get Ready.",
        "description": "",
        "summary": "Welcome to a revamped How To Invest newsletter as upcoming earnings from Google, Amazon and more bring these rules into focus.",
        "pubDate": "2026-02-03T01:50:55Z",
        "displayTime": "2026-02-03T01:50:55Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/aca8ec15-7d9b-337b-936d-7c0ff1638750/google-amazon-nvidia-lead.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/13a27f4f97c086470ff38a88cca15646",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pY5BjPos4QpHNNfuqfq88g--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/13a27f4f97c086470ff38a88cca15646.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/au_4fZO9C1Ru1LJcbrDx8A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/13a27f4f97c086470ff38a88cca15646.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/how-to-invest/how-to-invest-google-amazon-nvidia-lead-earnings-barrage-how-to-get-ready/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T00:49:51+00:00",
    "headline": "AbCellera Biologics Inc. (ABCL): A Bull Case Theory",
    "summary": "We came across a bullish thesis on AbCellera Biologics Inc. on topsecretstocks’s Substack. In this article, we will summarize the bulls’ thesis on ABCL. AbCellera Biologics Inc.’s share was trading at $3.6200 as of January 21st. ABCL’s trailing P/E was 19.92 according to Yahoo Finance. AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet […]",
    "url": "https://finance.yahoo.com/news/abcellera-biologics-inc-abcl-bull-004951347.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "34899ecc-990f-3d20-8fdb-b7459d1de7ab",
      "content": {
        "id": "34899ecc-990f-3d20-8fdb-b7459d1de7ab",
        "contentType": "STORY",
        "title": "AbCellera Biologics Inc. (ABCL): A Bull Case Theory",
        "description": "",
        "summary": "We came across a bullish thesis on AbCellera Biologics Inc. on topsecretstocks’s Substack. In this article, we will summarize the bulls’ thesis on ABCL. AbCellera Biologics Inc.’s share was trading at $3.6200 as of January 21st. ABCL’s trailing P/E was 19.92 according to Yahoo Finance. AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet […]",
        "pubDate": "2026-02-03T00:49:51Z",
        "displayTime": "2026-02-03T00:49:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/613180d2fa6faca5ddeea8020aa4e5f6",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ukO7Dxu9ji3eC8e4kTYdjg--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/613180d2fa6faca5ddeea8020aa4e5f6.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l4B7vEy.zrw5DqZYHB67PA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/613180d2fa6faca5ddeea8020aa4e5f6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abcellera-biologics-inc-abcl-bull-004951347.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abcellera-biologics-inc-abcl-bull-004951347.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABCL"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T03:14:59+00:00",
    "headline": "Eli Lilly’s New Weight Loss Plant And What It Might Mean For LLY’s Valuation",
    "summary": "Eli Lilly’s new Pennsylvania build and why it matters for the stock Eli Lilly (LLY) has drawn fresh attention after outlining plans to invest more than US$3.5b in a Pennsylvania facility dedicated to injectable weight loss medicines, including the experimental drug retatrutide. The project sits alongside upbeat analyst commentary on Lilly’s obesity and diabetes portfolio and a closely watched earnings report this week, which together put the company’s weight management franchise and capital...",
    "url": "https://finance.yahoo.com/news/eli-lilly-weight-loss-plant-031459271.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "db3d6cf8-9627-3605-a5e2-f17c805ae3f1",
      "content": {
        "id": "db3d6cf8-9627-3605-a5e2-f17c805ae3f1",
        "contentType": "STORY",
        "title": "Eli Lilly’s New Weight Loss Plant And What It Might Mean For LLY’s Valuation",
        "description": "",
        "summary": "Eli Lilly’s new Pennsylvania build and why it matters for the stock Eli Lilly (LLY) has drawn fresh attention after outlining plans to invest more than US$3.5b in a Pennsylvania facility dedicated to injectable weight loss medicines, including the experimental drug retatrutide. The project sits alongside upbeat analyst commentary on Lilly’s obesity and diabetes portfolio and a closely watched earnings report this week, which together put the company’s weight management franchise and capital...",
        "pubDate": "2026-02-03T03:14:59Z",
        "displayTime": "2026-02-03T03:14:59Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uZWvuDuy6_Wr6cKvxAFZcw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g78F5NO5pySOmBHzFi6.eA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-weight-loss-plant-031459271.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-weight-loss-plant-031459271.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T03:13:23+00:00",
    "headline": "Eli Lilly (LLY) Reports Q4: Everything You Need To Know Ahead Of Earnings",
    "summary": "Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting earnings this Wednesday before market hours. Here’s what to expect.",
    "url": "https://finance.yahoo.com/news/eli-lilly-lly-reports-q4-031323539.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "a3eae7f1-05cd-3e14-8baa-f9c4eda32e9a",
      "content": {
        "id": "a3eae7f1-05cd-3e14-8baa-f9c4eda32e9a",
        "contentType": "STORY",
        "title": "Eli Lilly (LLY) Reports Q4: Everything You Need To Know Ahead Of Earnings",
        "description": "",
        "summary": "Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting earnings this Wednesday before market hours. Here’s what to expect.",
        "pubDate": "2026-02-03T03:13:23Z",
        "displayTime": "2026-02-03T03:13:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/2d0b545c448821f8d1ada0dbe955b186",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "LLY Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/y7jUkGcVljBpqcrgSnimZQ--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/2d0b545c448821f8d1ada0dbe955b186.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fw6rZdJZ6CRFkLxhDmPhew--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/2d0b545c448821f8d1ada0dbe955b186.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-reports-q4-031323539.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-reports-q4-031323539.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]